Patents by Inventor Sushrut Krishnaji Kulkarni

Sushrut Krishnaji Kulkarni has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11850224
    Abstract: The present invention relates to a stable, aqueous, injectable solution comprising diclofenac and polyvinylpyrrolidone. The present invention also relates to processes for preparing the injectable solution.
    Type: Grant
    Filed: August 18, 2021
    Date of Patent: December 26, 2023
    Assignee: RK PHARMA INC.
    Inventors: Sushilkumar Dhanaji Patil, Nirav Ishwarlal Khatri, Alex Kochukunju George, Sushrut Krishnaji Kulkarni
  • Publication number: 20230301952
    Abstract: The present invention relates to stable, aqueous, parenteral solutions comprising diclofenac and polyvinylpyrrolidone, wherein the solutions are for parenteral (subcutaneous, intravenous and/or intramuscular) administration to a mammal.
    Type: Application
    Filed: June 2, 2023
    Publication date: September 28, 2023
    Applicant: RK PHARMA INC.
    Inventors: Kannan Essakimuthu MUTHAIYYAN, Debjani Manoj Singh, Nirav Ishwarlal Khatri, Sushrut Krishnaji Kulkarni, Alex Kochukunju George, Sushilkumar Dhanaji Patil, Jay Shantilal Kothari
  • Patent number: 11707443
    Abstract: The present invention relates to stable, aqueous, parenteral solutions comprising diclofenac and polyvinylpyrrolidone, wherein the solutions are for parenteral (subcutaneous, intravenous and/or intramuscular) administration.
    Type: Grant
    Filed: September 25, 2020
    Date of Patent: July 25, 2023
    Assignee: RK PHARMA INC.
    Inventors: Kannan Essakimuthu Muthaiyyan, Debjani Manoj Singh, Nirav Ishwarlal Khatri, Sushrut Krishnaji Kulkarni, Alex Kochukunju George, Sushilkumar Dhanaji Patil, Jay Shantilal Kothari
  • Publication number: 20210369659
    Abstract: The present invention relates to a stable, aqueous, injectable solution comprising diclofenac and polyvinylpyrrolidone. The present invention also relates to processes for preparing the injectable solution.
    Type: Application
    Filed: August 18, 2021
    Publication date: December 2, 2021
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sushilkumar Dhanaji PATIL, Nirav Ishwarlal KHATRI, Alex Kochukunju GEORGE, Sushrut Krishnaji KULKARNI
  • Patent number: 11110073
    Abstract: The present invention relates to a stable, aqueous, injectable solution comprising diclofenac and polyvinylpyrrolidone. The present invention also relates to processes for preparing the injectable solution.
    Type: Grant
    Filed: March 23, 2018
    Date of Patent: September 7, 2021
    Assignee: CADILA HEALTHCARE LIMITED
    Inventors: Sushilkumar Dhanaji Patil, Nirav Ishwarlal Khatri, Alex Kochukunju George, Sushrut Krishnaji Kulkarni
  • Publication number: 20210093598
    Abstract: The present invention relates to stable, aqueous, parenteral solutions comprising diclofenac and polyvinylpyrrolidone, wherein the solutions are for parenteral (subcutaneous, intravenous and/or intramuscular) administration.
    Type: Application
    Filed: September 25, 2020
    Publication date: April 1, 2021
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Kannan Essakimuthu MUTHAIYYAN, Debjani Manoj SINGH, Nirav Ishwarlal KHATRI, Sushrut Krishnaji KULKARNI, Alex Kochukunju GEORGE, Sushilkumar Dhanaji PATIL, Jay Shantilal KOTHARI
  • Publication number: 20190224332
    Abstract: The present invention relates to sterile injectable compositions comprising drug-phospholipid micelles. The present invention also relates to processes for the preparation of the sterile injectable compositions.
    Type: Application
    Filed: September 6, 2017
    Publication date: July 25, 2019
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sushilkumar Dhanaji PATIL, Smita Amarjitsing RAJPUT, Nirav Ishwarlal KHATRI, Alex Kochukunju GEORGE, Sushrut Krishnaji KULKARNI
  • Publication number: 20190151241
    Abstract: The present invention relates to stable pharmaceutical compositions of micafungin or a pharmaceutically acceptable salt thereof suitable for parenteral administration. In particular, the invention relates to stable injectable compositions of micafungin or a pharmaceutically acceptable salt thereof which does not require reconstitution. The invention also relates to processes for preparing such compositions and use thereof for the treatment of fungal infections.
    Type: Application
    Filed: November 16, 2018
    Publication date: May 23, 2019
    Inventors: Sushrut Krishnaji KULKARNI, Debjani Manoj SINGH, Tushar Surajmal NAHATA, Pradeep Jawarchandra CHOUHAN
  • Publication number: 20190060221
    Abstract: Present invention relates to a topical pharmaceutical composition of apremilast or its pharmaceutical acceptable salts in range of 0.01 to 25% w/w, isopropyl myristate and optionally with one or more pharmaceutically acceptable excipients and process for the preparation thereof. Further, topical formulations of this invention are therefore suitable for the treatment of psoriasis and psoriatic arthritis and they may also be used with some other medicaments.
    Type: Application
    Filed: August 21, 2018
    Publication date: February 28, 2019
    Inventors: Amit Arvind JOHARAPURKAR, Brijesh Kantilal SUTARIYA, Mukul R. JAIN, Sushrut Krishnaji KULKARNI, Kiran R. HOTHUR, Rajesh Prabhamal SIRWANI
  • Publication number: 20180271815
    Abstract: The present invention relates to a stable, aqueous, injectable solution comprising diclofenac and polyvinylpyrrolidone. The present invention also relates to processes for preparing the injectable solution.
    Type: Application
    Filed: March 23, 2018
    Publication date: September 27, 2018
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sushilkumar Dhanaji PATIL, Nirav Ishwarlal KHATRI, Alex Kochukunju GEORGE, Sushrut Krishnaji KULKARNI
  • Publication number: 20160235776
    Abstract: The present invention relates to a sustained release composition comprising topiramate and one or more pharmaceutical excipients, wherein the composition comprises a single population of beads, wherein each bead comprises: a) an inert core, b) an inner layer comprising topiramate, c) an outer layer comprising at least one sustained release material and at least one alkalizer. It also relates to methods of preparing such compositions and using those compositions in the treatment of neurological and/or psychiatric condition.
    Type: Application
    Filed: February 9, 2016
    Publication date: August 18, 2016
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sushrut Krishnaji KULKARNI, Ajaykumar HANDA, Amit Om Prakash GUPTA
  • Publication number: 20160045442
    Abstract: The present invention relates to stable pharmaceutical compositions of mesalamine. The composition of the invention is a capsule dosage form filled with a tablet. The invention also relates to process for preparing such compositions. The invention specifically relates to a composition of mesalamine wherein the composition is devoid of any reducing sugar or sugar alcohol.
    Type: Application
    Filed: August 13, 2015
    Publication date: February 18, 2016
    Inventors: Brij Khera, Sushrut Krishnaji Kulkarni, Hothur R. Kiran
  • Publication number: 20160022604
    Abstract: The present invention relates to pharmaceutical compositions comprising ospemifene or a pharmaceutically acceptable salt thereof prepared by direct compression process. The compositions of the invention may be advantageously used for the treatment or prevention of atrophy-related diseases or disorders in women, especially in women during or after the menopause.
    Type: Application
    Filed: July 22, 2015
    Publication date: January 28, 2016
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sushrut Krishnaji Kulkarni, Pavak Rajnikant Mehta, Ritesh Kapoor
  • Publication number: 20160008358
    Abstract: The present invention relates to stable aqueous pharmaceutical compositions of voriconazole or a pharmaceutically acceptable salt thereof suitable for parenteral administration. In particular, the invention relates to ready-to-use stable injectable compositions of voriconazole or a pharmaceutically acceptable salt thereof. The invention also relates to processes for the preparation of such compositions and use thereof for the treatment of fungal infections.
    Type: Application
    Filed: July 9, 2015
    Publication date: January 14, 2016
    Inventors: Sushrut Krishnaji Kulkarni, Debjani Manoj Singh, Tushar Surajmal Nahata, Jaimin Mahendrrabhai Patel
  • Publication number: 20160000732
    Abstract: The present invention relates to pharmaceutical compositions comprising ospemifene or a pharmaceutically acceptable salt thereof having an average particle size of more than 20 microns and one or more pharmaceutically acceptable excipients comprising at least one solubility enhancing agent. The compositions of the invention may be advantageously used for the treatment or prevention of atrophy-related diseases or disorders in women, especially in women during or after the menopause.
    Type: Application
    Filed: June 30, 2015
    Publication date: January 7, 2016
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sushrut Krishnaji Kulkarni, Pavak Rajnikant Mehta, Ritesh Kapoor
  • Publication number: 20150231081
    Abstract: The present invention relates to a delayed release composition comprising Posaconazole dissolved or molecularly dispersed in a polymer other than a hydroxypropyl methylcellulose derived polymer; wherein the composition is prepared by hot melt extruding an admixture of Posaconazole and the polymer. The present invention also provides a process of preparing said composition.
    Type: Application
    Filed: February 19, 2015
    Publication date: August 20, 2015
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: Sushrut Krishnaji KULKARNI, Pavak Rajnikant MEHTA, Ritesh KAPOOR, Rajesh Kumar Bharat MAHESHWARI
  • Patent number: 9101541
    Abstract: The present invention discloses a stable solid pharmaceutical matrix composition comprising sirolimus or pharmaceutically acceptable salts thereof along with one or more sugars.
    Type: Grant
    Filed: April 25, 2011
    Date of Patent: August 11, 2015
    Assignee: Cadila Healthcare Limited
    Inventors: Sunilendu Bhushan Roy, Sushrut Krishnaji Kulkarni, Kiritkumar Maulik Panchal, Shubhashchandra Shailendra Mandge
  • Publication number: 20150196518
    Abstract: The present invention relates to pharmaceutical compositions of mesalamine. The composition of the invention is a capsule dosage form filled with a tablet. The invention also relates to process for preparing such compositions. The invention specifically relates to a composition comprising an effective amount of mesalamine having higher bulk density.
    Type: Application
    Filed: January 9, 2015
    Publication date: July 16, 2015
    Inventors: Brij Khera, Sushrut Krishnaji Kulkarni, Kiran R. Hothur
  • Publication number: 20150037405
    Abstract: The present invention relates to pharmaceutical compositions of levodopa and carbidopa. In particular, the invention relates to modified release pharmaceutical compositions of levodopa and carbidopa with at least one organic acidic excipient. The invention also relates to processes for the preparation of such compositions and use thereof for treatment of Parkinson's disease.
    Type: Application
    Filed: August 4, 2014
    Publication date: February 5, 2015
    Inventors: Sushrut Krishnaji Kulkarni, Pavak Rajnikant Mehta, Sameer Sagar Kochar, Krishnakumar Vinubhai Patel
  • Publication number: 20140348931
    Abstract: The present invention relates to a sustained release pharmaceutical formulation comprising topiramate and one or more pharmaceutically acceptable excipients, wherein the formulation comprises two extended release (XR) components or a combination of an extended release (XR) component and immediate release (IR) component, wherein at least one component is in a matrix form. It also relates to method of preparing such formulations and using those formulations in the treatment of neurological and/or psychiatric condition.
    Type: Application
    Filed: May 27, 2014
    Publication date: November 27, 2014
    Applicant: CADILA HEALTHCARE LIMITED
    Inventors: SUSHRUT KRISHNAJI KULKARNI, AJAYKUMAR HANDA, AMIT OM PRAKASH GUPTA, PRUDHVI RAJU DANTULURI